{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:42:07Z","timestamp":1790883727157,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Intravenous leiomyomatosis is a rare, histologically benign yet biologically aggressive smooth muscle tumor. Previous studies have indicated that ovarian hormones may play a crucial role in the pathogenesis of intravenous leiomyomatosis. However, the question of whether the deprivation of ovarian estrogen, including bilateral oophorectomy, reduces tumor recurrence in intravenous leiomyomatosis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective cohort study, conducted across multiple centers in China from August 2003 to July 2023, focused on premenopausal patients with intravenous leiomyomatosis who underwent hysterectomy. Patients were categorized into either the bilateral oophorectomy group or the ovarian preservation group. The study compared disease-free survival (DFS) between these two groups. Univariate and multivariate analyses were employed to identify factors associated with DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The study included 219 patients, with 132 (60.3%) in the bilateral oophorectomy group and 87 (39.7%) in the ovarian preservation group. Generally, patients in the bilateral oophorectomy group were older, were more likely to have given birth, and had a higher proportion of extrauterine disease compared with those in the ovarian preservation group. Kaplan-Meier curves showed significantly lower recurrence rates in the bilateral oophorectomy group compared with the ovarian preservation group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.01). The cumulative recurrence rates at 3 years, 5 years, and 10 years were 0.8%, 2.6%, and 4.0%, respectively, in the bilateral oophorectomy group and 9.0%, 10.3%, and 14.0%, respectively, in the ovarian preservation group. Multivariate analysis for DFS demonstrated that ovarian preservation significantly increased the risk of tumor recurrence (adjusted hazard ratio 0.14, 95% CI, 0.04\u20130.52,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Simultaneous bilateral oophorectomy may reduce the risk of tumor recurrence for premenopausal women diagnosed with intravenous leiomyomatosis who undergo hysterectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006018","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T21:00:25Z","timestamp":1753995625000},"page":"377-385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Bilateral Oophorectomy Compared With Ovarian Preservation in Patients With Intravenous Leiomyomatosis Who Underwent Hysterectomy"],"prefix":"10.1097","volume":"146","author":[{"given":"Peipei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ehjci\/jeae280","article-title":"A silent intruder: intravenous leiomyomatosis extending to the heart and inferior vena cava","volume":"26","author":"Wang","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"1534933","DOI":"10.3389\/fmed.2025.1534933","article-title":"Pathological characteristics and clinical prognostic analysis of intravenous leiomyomatosis: a retrospective study of 43 cases","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-024-05919-9","article-title":"Pathological and molecular insights into intravenous leiomyomatosis: an integrative multi-omics study","volume":"23","author":"Yin","year":"2025","journal-title":"J Translat Med"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mva.2000.104601","article-title":"Intravenous leiomyomatosis with cardiac extension: tumor thrombectomy through an abdominal approach","volume":"31","author":"Harris","year":"2000","journal-title":"J Vasc Surg"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jvsv.2016.12.015","article-title":"Clinical characteristics and prognostic features of intravenous leiomyomatosis with inferior vena cava or intracardiac extension","volume":"5","author":"Zhang","year":"2017","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"101879","DOI":"10.1016\/j.suronc.2022.101879","article-title":"Manifestation and management of intravenous leiomyomatosis: a systematic review of the literature","volume":"45","author":"Lim","year":"2022","journal-title":"Surg Oncol"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/icvts\/ivt117","article-title":"Intracardiac leiomyomatosis: a comprehensive analysis of 194 cases","volume":"17","author":"Li","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"503","DOI":"10.21037\/atm-21-5376","article-title":"Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience","volume":"10","author":"Shi","year":"2022","journal-title":"Ann Transl Med"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"e2100336","DOI":"10.1200\/PO.21.00336","article-title":"Treatment of disseminated intravenous leiomyomatosis with ALK targeting crizotinib: a successful case report","volume":"6","author":"Barreto-Coelho","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12916-024-03344-9","article-title":"Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study","volume":"22","author":"Zhang","year":"2024","journal-title":"BMC Med"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"102624","DOI":"10.1016\/j.ctrv.2023.102624","article-title":"Estrogen deprivation effects of endocrine therapy in breast cancer patients: incidence, management and outcome","volume":"120","author":"Cucciniello","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"R12-20260826","first-page":"CD005997","article-title":"Hormone therapy for endometriosis and surgical menopause","author":"Al Kadri","year":"2009","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R13-20260826","first-page":"1124","article-title":"Postmenopausal intravenous leiomyomatosis with high levels of estradiol and estrogen receptor","volume":"100","author":"Kokawa","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/fca-2019-0002","article-title":"Uterine intravenous leiomyomatosis with femoral vein, intracaval, intracardiac and pulmonary artery extension","volume":"16","author":"Akinseye","year":"2020","journal-title":"Future Cardiol"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"e4902","DOI":"10.1097\/MD.0000000000004902","article-title":"Different surgical strategies of patients with intravenous leiomyomatosis","volume":"95","author":"Ma","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tjog.2017.04.017","article-title":"Intravenous leiomyomatosis of the uterus: a clinicopathological analysis of nine cases and literature review","volume":"56","author":"Low","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/AOG.0000000000001718","article-title":"Factors associated with recurrence after surgical resection in women with intravenous leiomyomatosis","volume":"128","author":"Yu","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/ijgc-2023-005108","article-title":"Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosis","volume":"34","author":"Zhang","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijgo.14932","article-title":"Intravenous leiomyomatosis of the uterus: preoperative and intraoperative assessment","volume":"163","author":"Gao","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"1020004","DOI":"10.3389\/fsurg.2022.1020004","article-title":"Clinical features and prognostic factors analysis of intravenous leiomyomatosis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Surg"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13023-021-02087-7","article-title":"The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis","volume":"16","author":"Liang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/ijgc-2020-001614","article-title":"Intracardiac intravenous leiomyomatosis: diagnosis and management","volume":"30","author":"Stilidi","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41379-020-0546-8","article-title":"Molecular and clinicopathologic characterization of intravenous leiomyomatosis","volume":"33","author":"Ordulu","year":"2020","journal-title":"Mod Pathol"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/RLU.0000000000004835","article-title":"68 Ga-FAPI and 18 F-FDG PET\/CT in intravenous leiomyomatosis","volume":"48","author":"Li","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00259-023-06509-5","article-title":"A rare case of intravenous leiomyomatosis extending along the right ovarian vein, right internal iliac, and inferior vena cava to the right atrium observed by [(18)F]F-FAPI PET\/CT","volume":"51","author":"Dong","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3348\/kjr.2016.17.2.289","article-title":"Uterine intravenous leiomyomatosis with intracardiac extension and pulmonary benign metastases on FDG PET\/CT: a case report","volume":"17","author":"Wang","year":"2016","journal-title":"Korean J Radiol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:02:25Z","timestamp":1787742145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006018","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"2025-03-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}